Cancer Center/Regenerative Medicine Laboratory
The Cancer Center/Regenerative Medicine Laboratory performs translational development of novel cell engineering methods leading to clinical production of novel therapies across a wide range of applications.
Typically, a new potential cellular therapy, emanating from discoveries in a basic research laboratory, is first tested for "proof of principal" in relevant in vitro and in vivo model systems and other appropriate models for cell distribution and toxicology. With sufficient preclinical data demonstrating safety and efficacy in relevant animal models, large-scale product manufacturing schemes are developed and production methods are tested. After cGMP manufacturing methods are validated, the clinical trial can be initiated.
This laboratory occupies 1,508 square feet and spans four function-specific research rooms currently assigned to:
- Master and Working Cell Bank manufacturing
- cell selection and activation
- cell and tissue production and expansion
- tumor vaccine production
This development center is supported by medical laboratory scientists.